import "./Residentslide.css";
import React from "react";

function Residentslide33() {
  return (
    <div class="body">
      <div class="references">
        <p>Case 1 references:</p>
        <ul>
          <li>
            Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of
            endometrial cancer: 2023. Int J Gynaecol Obstet.
            2023;162(2):383-394.
          </li>
          <li>
            Schwarz JK, Beriwal S, Esthappan J, et al. Consensus statement for
            brachytherapy for the treatment of medically inoperable endometrial
            cancer. Brachytherapy. 2015;14(5):587-599.
          </li>
          <li>
            Rauch GM, Kaur H, Choi H, et al. Optimization of MR imaging for
            pretreatment evaluation of patients with endometrial and cervical
            cancer. Radiographics. 2014;34(4):1082-1098.\
          </li>
          <li>
            Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic resonance
            image guided brachytherapy. Semin Radiat Oncol. 2014;24(3):181-191.
          </li>
          <li>
            Gill BS, Kim H, Houser C, et al. Image-based three-dimensional
            conformal brachytherapy for medically inoperable endometrial
            carcinoma. Brachytherapy. 2014;13(6):542-547.
          </li>
          <li>
            Georg P, Lang S, Dimopoulos JCA, et al. Dose-volume histogram
            parameters and late side effects in magnetic resonance image-guided
            adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol
            Phys. 2011;79(2):356-362.
          </li>
        </ul>
        <p>Case 2 references:</p>
        <ul>
          <li>
            Salib MY, Russell JHB, Stewart VR, et al. 2018 FIGO Staging
            Classification for Cervical Cancer: Added Benefits of Imaging.
            Radiographics. 2020;40(6):1807-1822.
          </li>
          <li>
            Tewari KS, Monk BJ. Evidence-Based Treatment Paradigms for
            Management of Invasive Cervical Carcinoma. J Clin Oncol.
            2019;37(27):2472-2489.
          </li>
          <li>
            Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A
            randomized trial of pelvic radiation therapy versus no further
            therapy in selected patients with stage IB carcinoma of the cervix
            after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic
            Oncology Group Study. Gynecol Oncol. 1999;73(2):177-183.
          </li>
          <li>
            Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent
            chemotherapy and pelvic radiation therapy compared with pelvic
            radiation therapy alone as adjuvant therapy after radical surgery in
            high-risk early-stage cancer of the cervix. J Clin Oncol.
            2000;18(8):1606-1613.
          </li>
          <li>
            Tanderup K, Fokdal LU, Sturdza A, et al. Effect of tumor dose,
            volume and overall treatment time on local control after
            radiochemotherapy including MRI guided brachytherapy of locally
            advanced cervical cancer. Radiother Oncol. 2016;120(3):441-446.
          </li>
          <li>
            Viswanathan AN, Beriwal S, De Los Santos JF, et al. American
            Brachytherapy Society consensus guidelines for locally advanced
            carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
            Brachytherapy. 2012;11(1):47-52.
          </li>
          <li>
            Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from
            Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and
            terms in 3D image based 3D treatment planning in cervix cancer
            brachytherapy with emphasis on MRI assessment of GTV and CTV.
            Radiother Oncol. 2005;74(3):235-245.
          </li>
          <li>
            Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: The
            outcome and prospect of two decades of evolution within the
            GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl
            Radiat Oncol. 2018;9:48-60.
          </li>
        </ul>
      </div>
    </div>
  );
}

export default Residentslide33;
